DE69928257D1 - Amidino- und guanidino-azetidinone tryptase-inhibitoren - Google Patents

Amidino- und guanidino-azetidinone tryptase-inhibitoren

Info

Publication number
DE69928257D1
DE69928257D1 DE69928257T DE69928257T DE69928257D1 DE 69928257 D1 DE69928257 D1 DE 69928257D1 DE 69928257 T DE69928257 T DE 69928257T DE 69928257 T DE69928257 T DE 69928257T DE 69928257 D1 DE69928257 D1 DE 69928257D1
Authority
DE
Germany
Prior art keywords
azetidinone
guanidino
amidino
tryptase inhibitors
tryptase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69928257T
Other languages
English (en)
Other versions
DE69928257T2 (de
Inventor
Gregory Bisacchi
A Slusarchyk
Uwe Treuner
C Sutton
Robert Zahler
Steven Seiler
R Kronenthal
E Randazzo
Zhongmin Xu
Zhongping Shi
D Schwinden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69928257D1 publication Critical patent/DE69928257D1/de
Publication of DE69928257T2 publication Critical patent/DE69928257T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69928257T 1998-06-25 1999-06-18 Amidino- und guanidino-azetidinon tryptase-inhibitoren Expired - Fee Related DE69928257T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9063698P 1998-06-25 1998-06-25
US90636P 1998-06-25
PCT/US1999/013811 WO1999067215A1 (en) 1998-06-25 1999-06-18 Amidino and guanidino azetidinone tryptase inhibitors

Publications (2)

Publication Number Publication Date
DE69928257D1 true DE69928257D1 (de) 2005-12-15
DE69928257T2 DE69928257T2 (de) 2006-08-03

Family

ID=22223632

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928257T Expired - Fee Related DE69928257T2 (de) 1998-06-25 1999-06-18 Amidino- und guanidino-azetidinon tryptase-inhibitoren

Country Status (24)

Country Link
EP (1) EP1089973B1 (de)
JP (1) JP2002518478A (de)
KR (1) KR20010053173A (de)
CN (1) CN1202081C (de)
AR (1) AR018945A1 (de)
AT (1) ATE309211T1 (de)
AU (1) AU752320B2 (de)
BR (1) BR9911373A (de)
CA (1) CA2336003A1 (de)
DE (1) DE69928257T2 (de)
ES (1) ES2249017T3 (de)
HU (1) HUP0104308A3 (de)
ID (1) ID27137A (de)
IL (1) IL140414A0 (de)
NO (1) NO20006380L (de)
NZ (1) NZ507627A (de)
PE (1) PE20000729A1 (de)
PL (1) PL345067A1 (de)
RU (1) RU2211832C2 (de)
TR (1) TR200003859T2 (de)
TW (1) TW548270B (de)
UY (1) UY25580A1 (de)
WO (1) WO1999067215A1 (de)
ZA (1) ZA200006028B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063704A1 (ja) 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
WO2006062110A1 (ja) * 2004-12-06 2006-06-15 Banyu Pharmaceutical Co., Ltd. ピペラジン誘導体
US8772297B2 (en) * 2010-02-17 2014-07-08 Kyoto University TGF-β signal transduction inhibitor
MX2015013374A (es) * 2013-03-20 2016-01-08 Hoffmann La Roche Derivados de urea y su uso como inhibidores de proteina de uniuon a acidos grasos (puag).
WO2014173855A1 (en) 2013-04-22 2014-10-30 Reuter Chemische Apparatebau Kg Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
EP3036219A4 (de) 2013-06-04 2017-08-23 Temple University Of The Commonwealth System Of Higher Education Neuartige beta-lactame als modulatoren einer glutamataufnahme und verfahren zur verwendung davon
CN106029064B (zh) 2014-02-07 2018-08-14 艾克赛特赫拉制药有限责任公司 治疗化合物和组合物
JP7397797B2 (ja) 2018-02-07 2023-12-13 エクセセーラ ファーマシューティカルズ インコーポレイテッド 治療用化合物および組成物
EP3778588A4 (de) * 2018-03-30 2021-04-28 Shanghai Meiyue Biotech Development Co., Ltd. Quaternäre lactamverbindung und ihre pharmazeutische verwendung davon
CN109988098A (zh) * 2019-05-23 2019-07-09 常州工程职业技术学院 一种(r)-n-叔丁氧羰基-3-羟甲基哌啶的合成方法
CN114040908A (zh) * 2019-06-25 2022-02-11 广东东阳光药业有限公司 一种凝血因子XIa抑制剂的晶型及其制备方法
AU2020378643A1 (en) 2019-11-08 2022-06-02 Coave Therapeutics Modified adeno-associated virus vectors and delivery thereof into the central nervous system
IL302444A (en) * 2020-11-06 2023-06-01 Coave Therapeutics Lactam muscle adeno-associated virus vectors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037819A (en) * 1990-06-04 1991-08-06 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5250677A (en) * 1990-06-04 1993-10-05 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5175283A (en) * 1990-06-04 1992-12-29 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5110812A (en) * 1990-06-04 1992-05-05 Bristol-Myers Squibb Co. Azetidin-2-one derivatives as serine protease inhibitors
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents
CA2266639A1 (en) * 1996-09-23 1998-03-26 Rajeshwar Singh 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators

Also Published As

Publication number Publication date
PE20000729A1 (es) 2000-10-28
ATE309211T1 (de) 2005-11-15
BR9911373A (pt) 2001-09-18
TR200003859T2 (tr) 2001-07-23
EP1089973A4 (de) 2001-12-12
AU4695099A (en) 2000-01-10
DE69928257T2 (de) 2006-08-03
EP1089973B1 (de) 2005-11-09
KR20010053173A (ko) 2001-06-25
EP1089973A1 (de) 2001-04-11
ZA200006028B (en) 2002-09-25
HUP0104308A2 (hu) 2002-04-29
NO20006380D0 (no) 2000-12-14
NZ507627A (en) 2003-12-19
UY25580A1 (es) 2001-08-27
ID27137A (id) 2001-03-01
AR018945A1 (es) 2001-12-12
NO20006380L (no) 2000-12-14
WO1999067215A1 (en) 1999-12-29
PL345067A1 (en) 2001-12-03
ES2249017T3 (es) 2006-03-16
JP2002518478A (ja) 2002-06-25
CA2336003A1 (en) 1999-12-29
CN1307560A (zh) 2001-08-08
CN1202081C (zh) 2005-05-18
IL140414A0 (en) 2002-02-10
HUP0104308A3 (en) 2002-06-28
AU752320B2 (en) 2002-09-12
RU2211832C2 (ru) 2003-09-10
TW548270B (en) 2003-08-21

Similar Documents

Publication Publication Date Title
DE69939689D1 (de) Caspase inhibitoren
NO20032753D0 (no) Forbindelse og anvendelse derav
ATE430158T1 (de) Hepatitis c tripeptide inhibitoren
EE200100003A (et) Ekskavaatorite ja teiste sarnaste seadiste hammaste ühendussõlm
IS5302A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
DK1137635T3 (da) N-substituerede 2-cyanopyrrolidiner
PL348648A1 (en) Cyclic tetrapeptide compound and use thereof
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
LV12150A (lv) Farneziltransferazes inhibitori
IS4930A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
BR9607412A (pt) Inibidor de trombina e composto
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DE69928257D1 (de) Amidino- und guanidino-azetidinone tryptase-inhibitoren
MA25391A1 (fr) Inhibiteurs d'alcenyl et alcynyl metalloproteases.
IS5990A (is) Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar
NO20003814D0 (no) Trombininhibitorer
DE69826216D1 (de) Lärmschutz
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
DK1135381T3 (da) Eletriptanhydrobromidmonohydrat
DE69733263D1 (de) Markierte elastase-inhibitoren
DK0997644T3 (da) Gerotormotor
DE29822631U1 (de) Elektronisches Winkelmeß- & Neigungsmeßgerät
DE29813249U1 (de) Telefonhäuschen
DE29809814U1 (de) Party-Teller
DE29817193U1 (de) Partydose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee